Examining Heterodimerization by Aryl C-N Coupling in Dynemicin Biosynthesis

Area of Science:

• Biochemistry
• Organic Chemistry
• Molecular Biology

Background:

• Dynemicins are enediyne antitumor antibiotics with a unique structure comprising enediyne and anthraquinone moieties.
• These two distinct halves are biosynthetically derived from a common linear precursor.
• The specific mechanism of their heterodimerization via an aryl C-N bond has remained largely uncharacterized.

Purpose of the Study:

• To investigate the mechanism of aryl C-N bond formation in dynemicin biosynthesis.
• To identify the proteins involved in the heterodimerization process.
• To elucidate the role of specific substituents on the anthraquinone precursor.

Main Methods:

• Experimental approaches including biochemical experiments and chemical model reactions.
• Enzyme pull-down assays to identify interacting proteins.
• Gene deletion studies (Orf14 and Orf16) to assess protein function.
• Structural comparisons using AlphaFold.

Main Results:

• Dynemicin heterodimerization is specific for anthracenyl iodide; bromo- and amino-substituted anthracenes do not support biosynthesis.
• Evidence supports an S_RN1 mechanism for aryl C-N coupling, involving electron transfer and radical intermediates.
• Orf14 and Orf16 were identified as proteins encoded by the dynemicin biosynthetic gene cluster.
• Deletion of orf14 abolished dynemicin production, implicating it in heterodimerization.
• Deletion of orf16 partially reduced production, suggesting an auxiliary role.

Conclusions:

• Orf14 is a key enzyme likely templating aryl C-N bond formation during dynemicin heterodimerization.
• The S_RN1 mechanism provides a framework for understanding this crucial biosynthetic step.
• Orf16 may play a supporting, non-catalytic role in the process.